The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?

Accelerated aging — when someone’s biological age is greater than their chronological age — could increase the risk of cancer tumors. That’s according to new research presented this week at the ...

The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?

In a recent study published in the journal Science Advances, researchers investigated the impact of early-life tobacco exposure on aging-related diseases. They found that in-utero tobacco exposure is ...

Avidity Biosciences (RNA) experienced a remarkable share price surge of ~900% from late 2023 to mid-2024. This is mainly due to the progress of three oligonucleotide candidates indicated for DMD, FSHD ...

The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?